← All companies
ELV
Elevance Health, Inc.
$382.77
+6.93 +1.84%
Key statistics
from XBRL data in SEC filingsMarket cap
$83.0B
Revenue (TTM)
$201B
Net income (TTM)
$4.96B
EPS (TTM)
$22.59
P/E ratio
16.9
Dividend yield
1.79%
Free cash flow
$3.17B
Cash
$10.2B
Total assets
$126B
Gross margin
—
52-week range
$273.71 – $436.24
Recent SEC filings
40 most recentAnnual, quarterly & current reports
10-Q
Quarter ended 2026-06-30
Jul 15, 2026
8-K
Results of operations (earnings release)
Jul 15, 2026
8-K
Regulation FD disclosure
Jun 10, 2026
8-K
Shareholder vote results
May 13, 2026
10-Q
Quarter ended 2026-03-31
Apr 22, 2026
8-K
Results of operations (earnings release)
Apr 22, 2026
8-K
Regulation FD disclosure
Mar 10, 2026
8-K
Other events
Mar 2, 2026
8-K
Director or officer change; Regulation FD disclosure
Feb 26, 2026
10-K
Fiscal year ended 2025-12-31
Feb 6, 2026
8-K
Results of operations (earnings release)
Jan 28, 2026
8-K
Director or officer change
Dec 10, 2025
8-K
Regulation FD disclosure
Nov 10, 2025
10-Q
Quarter ended 2025-09-30
Oct 21, 2025
8-K
Results of operations (earnings release)
Oct 21, 2025
8-K
Other events
Sep 15, 2025
8-K
Regulation FD disclosure
Sep 4, 2025
8-K
Director or officer change
Jul 28, 2025
10-Q
Quarter ended 2025-06-30
Jul 17, 2025
8-K
Results of operations (earnings release)
Jul 17, 2025
8-K
Regulation FD disclosure
May 28, 2025
8-K
Shareholder vote results
May 14, 2025
10-Q
Quarter ended 2025-03-31
Apr 22, 2025
8-K
Results of operations (earnings release)
Apr 22, 2025
8-K
Results of operations (earnings release); Regulation FD disclosure
Apr 17, 2025
8-K
Regulation FD disclosure
Mar 10, 2025
10-K
Fiscal year ended 2024-12-31
Feb 20, 2025
8-K
Results of operations (earnings release)
Jan 23, 2025
8-K
Other events
Oct 31, 2024
10-Q
Quarter ended 2024-09-30
Oct 17, 2024
8-K
Results of operations (earnings release)
Oct 17, 2024
10-Q
Quarter ended 2024-06-30
Jul 17, 2024
8-K
Results of operations (earnings release)
Jul 17, 2024
8-K
Regulation FD disclosure
Jun 12, 2024
8-K
Other events
May 30, 2024
8-K
Shareholder vote results
May 15, 2024
10-Q
Quarter ended 2024-03-31
Apr 18, 2024
8-K
Results of operations (earnings release)
Apr 18, 2024
8-K
Regulation FD disclosure
Mar 4, 2024
10-K
Fiscal year ended 2023-12-31
Feb 21, 2024